No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
NUWE Nuwellis
- 3.8000
- -0.0700-1.81%
Close Jul 19 16:00 ET
1.96MMarket Cap-17P/E (TTM)
3.9750High3.7400Low61.92KVolume3.7400Open3.8700Pre Close235.07KTurnover12.75%Turnover RatioLossP/E (Static)515.74KShares92.750052wk High2.22P/B1.85MFloat Cap3.340152wk Low--Dividend TTM485.58KShs Float6085800000.0000Historical High--Div YieldTTM6.07%Amplitude3.3400Historical Low3.7960Avg Price1Lot Size
Pre-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Nuwellis Achieves First QUELIMMUNE Sale, Cautions Investors
Express News | Nuwellis Marks First Commercial Sale of Quelimmune™ Therapy to Cincinnati Children’s
SeaStar Medical Begins Commercial Sale of Pediatric Acute Kidney Injury Treatment
SeaStar Medical (ICU) reported Friday the first commercial sale of the Quelimmune pediatric product to its US distribution partner Nuwellis (NUWE).The company said the US Food and Drug
Express News | Nuwellis Presents Clinical Evidence Demonstrating Efficacy Of Aquadex System At Heart Failure Society Of America Annual Scientific Meeting
New Evidence on Aquadex Ultrafiltration Therapy to Be Presented at HFSA 2024 Conference
MINNEAPOLIS, July 09, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients with fluid overload, is
Why Mainz Biomed Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Shares of Mainz Biomed N.V. (NASDAQ:MYNZ) rose sharply in today's pre-market trading after the company announced submission for the FDA Breakthrough Device Designation for its next generation CRC
Comments
$Nuwellis(NUWE.US$
short this to the center of earth. its a NO for children.
short this to the center of earth. its a NO for children.
1
$Nuwellis(NUWE.US$
Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’s
Nuwellis, Inc. (Nasdaq: NUWE) has announced its first commercial sale of QUELIMMUNE™ therapy to Cincinnati Children's. QUELIMMUNE, developed by SeaStar Medical, is a novel treatment for pediatric patients with acute kidney injury (AKI) due to sepsis requiring kidney replacement therapy. The therapy, accessible under an FDA Humanitarian Device Exemption, has shown a 77% survival rate in ea...
Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’s
Nuwellis, Inc. (Nasdaq: NUWE) has announced its first commercial sale of QUELIMMUNE™ therapy to Cincinnati Children's. QUELIMMUNE, developed by SeaStar Medical, is a novel treatment for pediatric patients with acute kidney injury (AKI) due to sepsis requiring kidney replacement therapy. The therapy, accessible under an FDA Humanitarian Device Exemption, has shown a 77% survival rate in ea...
$Nuwellis(NUWE.US$ Nuwellis Presents Clinical Evidence Demonstrating Efficacy Of Aquadex System At Heart Failure Society Of America Annual Scientific Meeting
3
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg